BioLife Solutions
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BioLife Solutions generated cash of -$12,498,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,591,000 last year. Net change in cash is therefore $15,965,000.
Cash Flow
| 2013 | 146.00K | -236.67K | 50.45K |
|---|---|---|---|
| 2015 | -4.97M | 4.23M | 368.75K |
| 2016 | -4.32M | 393K | 3.16M |
| 2017 | 605K | -144K | 4.79M |
| 2018 | 2.34M | -6.5M | 28.14M |
| 2019 | 1.21M | -27.01M | 1.59M |
| 2020 | 6.51M | -23.73M | 101.22M |
| 2021 | -4.83M | -12.64M | -2.77M |
| 2022 | -8.48M | -58.11M | 16.31M |
| 2023 | -12.49M | 17.83M | 10.59M |
BLFS Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 19.47M | 69.87M | 90.45M | 6.44M | 30.65M | 6.66M | 1.40M | 2.17M | 2.53M | 196.47K |
Operating activities | ||||||||||
Net income | -66.42M | -139.80M | -7.63M | 2.66M | -1.65M | 3.26M | -2.51M | -8.04M | -4.99M | -1.08M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 12.29M | 16.47M | 12.86M | 5.06M | 1.79M | 338K | 338.68K | 368.10K | 343.21K | 247.07K |
Stock-based compensation expense | 31.67M | 25.33M | 13.95M | 5.98M | 3.04M | 1.51M | 1.27M | 776.99K | 511.45K | 248.20K |
| Deferred income tax benefit | 31.67M | 25.33M | 13.95M | 5.98M | 3.04M | 1.51M | 1.27M | 776.99K | 511.45K | 248.20K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 15.35M | -10.75M | -10.13M | -1.78M | -290K | -2.02M | 172.33K | -264.35K | -27.66K | -409.16K |
Inventories | -8.55M | -6.55M | 114K | -629K | -3.77M | -1.66M | -88.96K | -290.83K | -869.41K | 235.47K |
Accounts payable | -8.42M | 414K | 2.01M | -171K | 768K | -11K | 20.58K | 233.48K | 194.38K | 4.57K |
Cash generated by operating activities | -12.49M | -8.48M | -4.83M | 6.51M | 1.21M | 2.34M | 605K | -4.32M | -4.97M | 146.00K |
Investing activities | ||||||||||
Purchases Of Investments | -27.09M | -53.11M | -6.37M | -1M | -2.5M | -6M | 0 | 0 | -1.40M | 0 |
Investments In Property Plant And Equipment | -6.38M | -10.38M | -8.38M | -4.63M | -675K | -500K | -143.76K | -1.25M | -1.41M | -236.67K |
Acquisitions Net | 0 | 0 | 1.55M | -15.94M | -22.18M | -6M | 0 | 0 | 1.37B | 0 |
Cash generated by investing activities | 17.83M | -58.11M | -12.64M | -23.73M | -27.01M | -6.5M | -144K | 393K | 4.23M | -236.67K |
Financing activities | ||||||||||
Common Stock Issued | 10.24M | -131K | 1.27M | 100.12M | 1.75M | 20M | 3.92M | 166.76K | 368.75K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | -436K | -106.25K | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -4.25M | 0 | 0 | 0 | 0 |
Repayments of term debt | -498K | 17.83M | -2.89M | -2.17M | 0 | -25K | 976K | -3M | 0 | 0 |
Cash used in financing activities | 10.59M | 16.31M | -2.77M | 101.22M | 1.59M | 28.14M | 4.79M | 3.16M | 368.75K | 50.45K |
Net Change In Cash | 15.96M | -50.39M | -20.58M | 84.00M | -24.20M | 23.99M | 5.25M | -767K | -365.5K | -40.20K |
Cash at end of period | 35.43M | 19.47M | 69.87M | 90.45M | 6.44M | 30.65M | 6.66M | 1.40M | 2.17M | 156.27K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |